Last reviewed · How we verify
mRNA COVID-19
mRNA COVID-19 is a Biologic drug developed by Duke University. It is currently FDA-approved.
At a glance
| Generic name | mRNA COVID-19 |
|---|---|
| Sponsor | Duke University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations (PHASE4)
- Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction (PHASE4)
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (PHASE1)
- Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals (PHASE2, PHASE3)
- Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia. (PHASE3)
- COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose
- Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly
- Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- mRNA COVID-19 CI brief — competitive landscape report
- mRNA COVID-19 updates RSS · CI watch RSS
- Duke University portfolio CI
Frequently asked questions about mRNA COVID-19
What is mRNA COVID-19?
mRNA COVID-19 is a Biologic drug developed by Duke University.
Who makes mRNA COVID-19?
mRNA COVID-19 is developed and marketed by Duke University (see full Duke University pipeline at /company/duke-university).
What development phase is mRNA COVID-19 in?
mRNA COVID-19 is FDA-approved (marketed).
Related
- Manufacturer: Duke University — full pipeline